The COVID-19 pandemic: a catalyst to improve clinical trials.

Gaba, Prakriti; Bhatt, Deepak L

Gaba, Prakriti; Bhatt, Deepak L.

Gaba P; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Bhatt DL; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. dlbhattmd@post.harvard.edu.

Nat Rev Cardiol ; 17(11): 673-675, 2020 11.

Article in English | MEDLINE | ID: covidwho-740038

Subject(s)

Clinical Trials as Topic/standards; Coronavirus Infections/epidemiology; Pandemics; Pneumonia, Viral/epidemiology; COVID-19; Humans; Informed Consent/standards; Patient Selection; Quality Improvement; Telemedicine/standards

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Clinical Trials as Topic / Coronavirus Infections / Pandemics Type of study: Observational study / Prognostic study / Qualitative research / Randomized controlled trials Limits: Humans Language: English Journal: Nat Rev Cardiol Journal subject: Cardiology Year: 2020 Document Type: Article Affiliation country: S41569-020-00439-7

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google